This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi-Aventis Recherche & Développement. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Laetitia Ledein - Innovator in Therapeutic Applications
Introduction
Laetitia Ledein is an accomplished inventor based in Paris, France. She is currently associated with Sanofi, a global healthcare company. Although she has not yet been granted any patents, her work focuses on innovative therapeutic applications that hold promise for various medical conditions.
Latest Patent Applications
Laetitia Ledein's notable patent application is titled "CRF2 Receptor Agonists and Their Use in Therapy." This application presents compounds that are peptides comprising a specific amino acid sequence or pharmaceutically acceptable salts thereof. The compounds are designed to act as agonists of the corticotropin-releasing factor receptor 2 (CRF2). They are particularly useful in therapy, especially for the treatment or prevention of cardiovascular diseases, obesity, and diabetes.
Conclusion
Laetitia Ledein's contributions to the field of therapeutic innovations reflect her commitment to advancing medical science. Her work has the potential to impact the treatment of significant health issues, showcasing her role as a forward-thinking inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile